Plethora Pharma

Plethora Pharma Solutions, a subsidiary of Endurance RP Limited (formerly Regent Pacific Group), is a specialty pharmaceutical company focused on urological health. The company's lead product is Fortacin (also known as PSD502 or Senstend), a topical spray containing a eutectic mixture of lidocaine and prilocaine designed to treat premature ejaculation. Fortacin is approved and marketed in several European markets and is undergoing clinical development for the US market. Plethora's business model involves partnering with larger pharmaceutical firms, such as Recordati and Wanbang Pharmaceutical, for the commercialization and distribution of its products globally.